A nurse is reviewing the laboratory results of a client who has atrial fibrillation and a prescription for warfarin. After informing the provider that the INR is 2.5, the nurse should expect which of the following prescriptions?

A. I will check the client's INR before administering the heparin:
Checking the International Normalized Ratio (INR) is more relevant for monitoring the effects of warfarin, not heparin. Heparin is typically monitored by activated partial thromboplastin time (aPTT) or anti-Xa levels.
B. "I will apply pressure for 1 minute after the injection:"
Applying gentle pressure to the injection site for about 1 minute after administering heparin is appropriate to prevent bleeding or bruising. Since heparin is an anticoagulant, there's an increased risk of bleeding at the injection site.
C. I will massage the site after injecting the heparin:
Massaging the site after injecting heparin is not recommended. It can increase the risk of hematoma formation. After subcutaneous injection, it is generally advised to avoid massaging the site.
D. I will aspirate before administering the heparin:
Aspiration is not recommended when administering heparin subcutaneously, as it can increase the risk of tissue damage and bruising. The nurse should inject the heparin without aspirating.

A. Anxiety disorder: Anxiety disorder is generally not a contraindication for the use of oral contraceptives. However, it's essential to consider the overall health of the individual and potential interactions with medications used to manage anxiety.
B. History of deep-vein thrombosis (Correct Answer): A history of deep-vein thrombosis (DVT) is a significant contraindication to the use of oral contraceptives. Estrogen-containing contraceptives can increase the risk of blood clot formation, and individuals with a history of DVT are at an elevated risk for thrombotic events.
C. Ovarian cysts: Ovarian cysts alone are not a contraindication for oral contraceptives. In fact, oral contraceptives are sometimes prescribed to help regulate menstrual cycles and prevent the formation of certain types of ovarian cysts.
D. Client age of 36 years: Age alone is not a strict contraindication for oral contraceptives. However, as women age, especially beyond 35 years, healthcare providers may consider other risk factors such as smoking, hypertension, and cardiovascular health when prescribing oral contraceptives.